Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Live Combined Bifidobacterium and Lactobacillus on Glycemic Control and Other Diabetes-Related Outcomes in People With Type 1 Diabetes:a Single-blind Randomized Controlled Trial

NCT03556631 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.

NCT NCT03556631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03556631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Live Combined Bifidobacterium and Lactobacillus on Glycemic Control and Other Diabetes-Related Outcomes in People With Type 1 Diabetes:a Single-blind Randomized Controlled Trial
Lead sponsor
Shenzhen People's Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2020
Completion date
October 30, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

probiotics, type 1 diabetes mellitus